Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Unique Song "Needle Free" Spreads Message of Hope to Millions Living with Diabetes
  • USA - English


News provided by

Curran Public Relations

Nov 02, 2015, 08:05 ET

Share this article

Share toX

Share this article

Share toX

NEEDLE FREE available on iTunes. For every iTunes download, 10 cents will be donated to a foundation that helps people needing insulin who can't afford it.
NEEDLE FREE available on iTunes. For every iTunes download, 10 cents will be donated to a foundation that helps people needing insulin who can't afford it.

NASHVILLE, TENN. (PRWEB) November 02, 2015 -- Seeking to spread a message of hope to the estimated 29 million Americans living with diabetes, an American Idol contestant and a country music star have joined forces with medical professionals to lift their voices in song and tell the world it is possible to be living “Needle Free.”

'Needle Free' is the new song spreading a message of hope to the estimated 29 million Americans living with diabetes.

Post this

“Needle Free” features the soulful voice of American Idol Season 14 contestant Adam Lasher and the pure country stylings of Nashville’s Amanda Jo, each of whom is living very successfully with Type 1 diabetes. Two dedicated endocrinologists, experts in the care of patients with diabetes, co-wrote and produced the song.

“Needle Free” is available for download from iTunes. For every iTunes download, 10 cents will be donated to a foundation that helps people needing insulin who can't afford it.

The promise of a needle-free life is music to the ears of people who suffer from Type 1 diabetes, an autoimmune disease where the pancreas does not produce the critical hormone insulin. Since the discovery of insulin in 1921, patients with Type 1 diabetes have required daily injections of insulin and painful finger-stick blood glucose monitoring in order to survive. However, as “Needle Free” promises, change is coming with the arrival of needle-free insulin delivery, minimally invasive glucose monitoring, and the exciting possibility of new medications restoring the body’s ability to regenerate insulin-producing cells.

Co-writer credits include Dr. Mack Harrell of Florida, immediate past-president of the American Association of Clinical Endocrinologists (AACE), and endocrinologist Dr. Claresa Levetan of Pennsylvania, former member of the AACE board of directors, along with Lasher, Amanda Jo, and Nashville songwriter/producer Billy Lee. The track was recorded in Nashville by renowned country-pop producer Kim Copeland.

“We are on the cusp of amazing new science that will help the millions of Americans living with Type 1 diabetes,” said Dr. Mack Harrell, immediate past-president of the American Association of Clinical Endocrinologists (AACE). “It is my hope that ‘Needle Free’ will serve as a springboard for a national conversation about how important it is to have diabetes education and the need for continued support for diabetes research.”

“As someone who has been studying this disease for more than 30 years, I can say without a doubt that this is an exciting time for people living with diabetes,” said Dr. Claresa Levetan, whose career path was shaped by her seeing as a young child how a neighbor’s body was ravaged by the disease. “New technologies and research developments clearly show that there will be a time in the near future when insulin-dependent diabetes patients will be living ‘Needle Free’.”

“The song ‘Needle Free’ is a way to communicate hope and optimism to people who suffer from this disease,” said Dr. Levetan. “People may think they are sentenced to a lifetime of needle pricks and pain, but change is coming. It is only a matter of time.”

To preview the making of “Needle Free” and download an MP3 copy, visit http://www.empoweryourhealth.org/needle-free. Watch the video trailer at https://youtu.be/VX-C8pq7b3I.

Interviews with the song performers, doctors and composers are available upon request.

####

About Needle Free

“Needle Free” is the new song spreading a message of hope to the estimated 29 million Americans living with diabetes. Performed by American Idol Season 14 contestant Adam Lasher, (http://www.adamlasherband.com/) and Nashville’s Amanda Jo (http://www.amandajocountry.com/), both of whom are living very successfully with Type 1 diabetes, it was written by Dr. Mack Harrell, immediate past-president of the American Association of Clinical Endocrinologists (AACE), and endocrinologist Dr. Claresa Levetan, former member of the AACE board of directors. For every iTunes download, 10 cents will be donated to a foundation that helps people needing insulin who can't afford it. For more information visit http://www.Facebook.com/NeedleFreeSong and follow @needlefreesong on Twitter and Instagram.

Dan Curran, Curran Public Relations, http://www.CurranPR.com, +1 (770) 658-9586, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.